Analysis of novel proteins produced by vascular tissues and their clinical application

血管组织产生的新型蛋白质分析及其临床应用

基本信息

  • 批准号:
    11557052
  • 负责人:
  • 金额:
    $ 8.19万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

We cloned a novel secreted protein, DANCE, from mouse embryonic hearts by the signal sequence-trap method. Its human and rat counterparts were also identified. It has shown to be a secreted protein with six calcium-binding EGF domains and one RGD sequence through which it binds to integrins. Its chromosomal localization was determined to be on human chromosome 14q32.1 by FISH method. There is to date no report of inherited diseases in this locus. We proceeded to analyze the expression profiles of DANCE both in normal and diseased animals. On the development of mouse, its expression is first identified on migrating nerual crest cells, their derivative branchial arch mesenchymal cells and the pericardium at embronic day 9.5. Atday 12.5-dpc, it is expressed in the cardiac outflow tract and aorta (both in endothelial cells and in smooth muscle cells), endocardial cushion tissues, head mesenchyme, intersomitic tissues and several other mesenchymal tissues. In 14.5-dpc embryos, some neural c … More rest-derived tissues such as head mesenchyme, cardiac outflow tract, and symphathetic ganglia continue to express DANCE, whereas other neural crest tissues such as adrenal gland do not. In adult aorta, DANCE expression is largely diminished. However, intense focal expression is found at intercostal branching points in the thoracic aorta. This coinsides with atherogenic region where alternation of hemodynamic stress at branching regions is implicated on the induction of atherogenesis. Accordingly, we studied DANCE expression in atherosclerotic vessels using LDL receptor-deficient mice fed with a high cholesterol diet. Endothelial cells overlying the plaques exhibited a significant increase in DANCE mRNA expression compared with normal regions of the same vessel. We could also find that DANCE mRNA expression is markedly increased in arteries following balloon injury with the highest levels seen at 14 days, coinciding with decreasing smooth muscle cell replication. By in situ hybridization of injured vessels, DANCE mRNA is observed in both endothelial cells and smooth muscle cells, with their maximal expression found at the spatial and temporal condition of returning from cell-proliferation to quiescence, suggesting that DANCE may affect cell growth as a "brake" in autocrine or paracrine manner when proliferation should stop. Thus DANCE, as a secreted protein of systemic applicable form, harbors a potential of clinical application like the prevention of restenosis after PTCA.We have succeeded in generating knockout mice of DANCE and found the abnormal phenotype, the elucidation of whose mechanism is one of the present targets of our study. Less
我们用信号序列捕获法从小鼠胚胎心脏中克隆了一个新的分泌蛋白DANCE。它的人类和大鼠对应物也被确定。它已被证明是一种分泌蛋白,具有6个钙结合EGF结构域和一个RGD序列,通过该序列它与整联蛋白结合。经FISH检测其染色体定位于人染色体14q32.1。迄今为止,没有关于该地区遗传性疾病的报告。我们继续分析DANCE在正常和患病动物中的表达谱。在小鼠的发育过程中,其表达首先在胚胎9.5天的迁移神经嵴细胞、其衍生的鳃弓间充质细胞和心包上被鉴定。在12.5-dpc时,它在心脏流出道和主动脉(在内皮细胞和平滑肌细胞中)、内膜垫组织、头部间充质、体间组织和一些其它间充质组织中表达。在14.5-dpc胚胎中,一些神经c ...更多信息 静息来源的组织如头部间充质、心脏流出道和交感神经节继续表达DANCE,而其它神经嵴组织如肾上腺则不表达。在成人主动脉中,DANCE表达大大减少。然而,在胸主动脉的肋间分支点发现了强烈的局灶性表达。这与动脉粥样硬化形成区域相一致,其中分支区域的血流动力学应力的改变与动脉粥样硬化形成的诱导有关。因此,我们研究了DANCE的表达在动脉粥样硬化血管使用LDL受体缺陷小鼠喂养高胆固醇饮食。与同一血管的正常区域相比,斑块上的内皮细胞表现出DANCE mRNA表达的显著增加。我们还发现,DANCE mRNA表达在球囊损伤后动脉中显著增加,在14天时观察到最高水平,与平滑肌细胞复制减少一致。损伤血管的原位杂交结果显示,DANCE mRNA在内皮细胞和平滑肌细胞中均有表达,且在细胞从增殖状态恢复到静止状态的时空条件下表达最高,提示DANCE可能以自分泌或旁分泌的方式影响细胞的生长。因此,DANCE作为一种分泌型的全身应用蛋白,具有预防PTCA术后再狭窄等临床应用的潜力。我们成功地建立了DANCE基因敲除小鼠,发现了DANCE基因的异常表型,阐明其机制是目前的研究目标之一。少

项目成果

期刊论文数量(182)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Matsumori A, et al.: "Pimobendan inhibits the activation of transcription factor NF-κB.A mechanism which explains its inhibition of cytokine production and inducible nitric oxide synthase."Life Sci. 67. 2513-2519 (2000)
Matsuori A 等人:“匹莫苯丹抑制转录因子 NF-κB 的激活。这解释了其抑制细胞因子产生和诱导型一氧化氮合酶的机制。”Life Sci. 67. 2513-2519 (2000)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nishimura H, et al.: "Autoimmune dilated cardiomyopathy in PD-1 receptor deficient mice."Science. 291. 391-322 (2001)
Nishimura H 等人:“PD-1 受体缺陷小鼠的自身免疫性扩张型心肌病。”科学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Matsumori A.: "The role of inflammatory mediators in the failing heart : Immunomodulation of cytokines in experimental models of heart failure."Heart Failure Reviews. 6. 129-136 (2001)
Matsumori A.:“炎症介质在心脏衰竭中的作用:心力衰竭实验模型中细胞因子的免疫调节。”心力衰竭评论。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takashige N, Naruse TK, Matsumori A, Hara M, Nagai S, Morimoto S, Hiramitsu S, Sasayama S, Inoko H.: "Genetic polymorphisms at the tumour necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis."Tissue Antigens. 54. 191-193 (1999)
Takashige N、Naruse TK、Matsumori A、Hara M、Nagai S、Morimoto S、Hiramitsu S、Sasayama S、Inoko H.:“心脏结节病中肿瘤坏死因子位点(TNFA 和 TNFB)的遗传多态性。”组织抗原。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Furukawa Y, Matsumori A, Ohashi N, Shioi T, Ono K, Harada A, Matsushima K, Sasayama S.: "Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries."Circ Res.
Furukawa Y、Matsumori A、Ohashi N、Shioi T、Ono K、Harada A、Matsushima K、Sasayama S.:“抗单核细胞趋化蛋白-1/单核细胞趋化和激活因子抗体抑制受损大鼠颈动脉中的新内膜增生。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SASAYAMA Shigetake其他文献

SASAYAMA Shigetake的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SASAYAMA Shigetake', 18)}}的其他基金

Analysis of the role of p38 MAP kinase in heart failure using transgenic mice
使用转基因小鼠分析 p38 MAP 激酶在心力衰竭中的作用
  • 批准号:
    11307012
  • 财政年份:
    1999
  • 资助金额:
    $ 8.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A).
Analysis of signal transduction among cells in the pathogenesis of heart failure and its application for the diagnosis and treatment
心力衰竭发病机制中细胞间信号转导分析及其在诊治中的应用
  • 批准号:
    08407018
  • 财政年份:
    1996
  • 资助金额:
    $ 8.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
DEVELOPMENT OF GENE THERAPY FOR CARDIOVASCULAR DISEASES
心血管疾病基因治疗的发展
  • 批准号:
    08044273
  • 财政年份:
    1996
  • 资助金额:
    $ 8.19万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Cellular interaction in pathogenesis of cardiac dysfuction
心功能不全发病机制中的细胞相互作用
  • 批准号:
    07044253
  • 财政年份:
    1995
  • 资助金额:
    $ 8.19万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Oxydant Stress in the Cardiomyocyte and Its Roles on the Cellular Signaling
心肌细胞的氧化应激及其对细胞信号传导的作用
  • 批准号:
    07557343
  • 财政年份:
    1995
  • 资助金额:
    $ 8.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Molecular Pathogenesis of Virus-Induced Myocardial Injury
病毒引起的心肌损伤的分子发病机制
  • 批准号:
    05044162
  • 财政年份:
    1993
  • 资助金额:
    $ 8.19万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Studies on the cytokines in heart failure
心力衰竭中细胞因子的研究
  • 批准号:
    05404034
  • 财政年份:
    1993
  • 资助金额:
    $ 8.19万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (A)
Experimental Studies on the Occurrence of Cardiac Hypertrophy in Ischemic Heart and Its Possible Mechanisms
缺血性心脏心肌肥厚发生及其可能机制的实验研究
  • 批准号:
    63480224
  • 财政年份:
    1988
  • 资助金额:
    $ 8.19万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似国自然基金

豁痰解毒通络方干预实验性AS家兔颈动脉PTCA术后内膜增生的金属硫蛋白-内质网应激-自噬机制研究
  • 批准号:
    81774226
  • 批准年份:
    2017
  • 资助金额:
    25.0 万元
  • 项目类别:
    面上项目
生长因子-毒素融合蛋白对PTCA后再狭窄预防的基础研究
  • 批准号:
    39670316
  • 批准年份:
    1996
  • 资助金额:
    9.5 万元
  • 项目类别:
    面上项目
P53与AS和PTCA术后再狭窄发生机制制及基因治疗的研究
  • 批准号:
    39370305
  • 批准年份:
    1993
  • 资助金额:
    5.5 万元
  • 项目类别:
    面上项目
反意寡核苷酸拮抗PTCA后血管内皮细胞sis基因超常表达
  • 批准号:
    39270319
  • 批准年份:
    1992
  • 资助金额:
    7.0 万元
  • 项目类别:
    面上项目
补阳还五汤实验预防家兔模拟PTCA后再狭窄及其机制研究
  • 批准号:
    39270862
  • 批准年份:
    1992
  • 资助金额:
    4.0 万元
  • 项目类别:
    面上项目

相似海外基金

THROMBIN INHIBITION IN RESTENOSIS AFTER PTCA
PTCA 术后再狭窄中的凝血酶抑制
  • 批准号:
    6302337
  • 财政年份:
    2000
  • 资助金额:
    $ 8.19万
  • 项目类别:
THROMBIN INHIBITION IN RESTENOSIS AFTER PTCA
PTCA 术后再狭窄中的凝血酶抑制
  • 批准号:
    6110466
  • 财政年份:
    1999
  • 资助金额:
    $ 8.19万
  • 项目类别:
RIBOZYMES FOR THE PREVENTION OF RESTENOSIS AFTER PTCA
用于预防 PTCA 术后再狭窄的核酶
  • 批准号:
    6184488
  • 财政年份:
    1998
  • 资助金额:
    $ 8.19万
  • 项目类别:
RIBOZYMES FOR THE PREVENTION OF RESTENOSIS AFTER PTCA
用于预防 PTCA 术后再狭窄的核酶
  • 批准号:
    6015667
  • 财政年份:
    1998
  • 资助金额:
    $ 8.19万
  • 项目类别:
RIBOZYMES FOR THE PREVENTION OF RESTENOSIS AFTER PTCA
用于预防 PTCA 术后再狭窄的核酶
  • 批准号:
    2678095
  • 财政年份:
    1998
  • 资助金额:
    $ 8.19万
  • 项目类别:
THROMBIN INHIBITION IN RESTENOSIS AFTER PTCA
PTCA 术后再狭窄中的凝血酶抑制
  • 批准号:
    6273050
  • 财政年份:
    1998
  • 资助金额:
    $ 8.19万
  • 项目类别:
MK-383 AND HEPARIN VS PLACEBO AND HEPARIN IN PTCA/ATHERECTOMY
MK-383 和肝素与安慰剂和肝素在 PTCA/动脉粥样斑块切除术中的比较
  • 批准号:
    6252456
  • 财政年份:
    1997
  • 资助金额:
    $ 8.19万
  • 项目类别:
Study on Design of Macromolecular Matrix for PTCA Application to Suppress Coronary Restenosis
PTCA应用抑制冠状动脉再狭窄的高分子基质设计研究
  • 批准号:
    09680855
  • 财政年份:
    1997
  • 资助金额:
    $ 8.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of constrictive remodeling at the site of restenosis after PTCA
PTCA术后再狭窄部位收缩性重塑机制
  • 批准号:
    09670198
  • 财政年份:
    1997
  • 资助金额:
    $ 8.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
THROMBIN INHIBITION IN RESTENOSIS AFTER PTCA
PTCA 术后再狭窄中的凝血酶抑制
  • 批准号:
    6242460
  • 财政年份:
    1997
  • 资助金额:
    $ 8.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了